Citius Pharmaceuticals Inc. (CTXR) having phase III product. Still trading below $3? Quote http://www.rttnews.com/2921898/xent-trims-revenue-outlook-ctxr-on-watch-busy-year-ahead-for-nlnk.aspx?refresh=1